Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting dendritic cells to treat multiple sclerosis.
Comabella M, Montalban X, Münz C, Lünemann JD. Comabella M, et al. Among authors: lunemann jd. Nat Rev Neurol. 2010 Sep;6(9):499-507. doi: 10.1038/nrneurol.2010.112. Epub 2010 Aug 17. Nat Rev Neurol. 2010. PMID: 20717105 Review.
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.
Malhotra S, Costa C, Eixarch H, Keller CW, Amman L, Martínez-Banaclocha H, Midaglia L, Sarró E, Machín-Díaz I, Villar LM, Triviño JC, Oliver-Martos B, Parladé LN, Calvo-Barreiro L, Matesanz F, Vandenbroeck K, Urcelay E, Martínez-Ginés ML, Tejeda-Velarde A, Fissolo N, Castilló J, Sanchez A, Robertson AAB, Clemente D, Prinz M, Pelegrin P, Lünemann JD, Espejo C, Montalban X, Comabella M. Malhotra S, et al. Among authors: lunemann jd. Brain. 2020 May 1;143(5):1414-1430. doi: 10.1093/brain/awaa084. Brain. 2020. PMID: 32282893 Free article.
Targeting Inflammasomes to Treat Neurological Diseases.
Lünemann JD, Malhotra S, Shinohara ML, Montalban X, Comabella M. Lünemann JD, et al. Ann Neurol. 2021 Aug;90(2):177-188. doi: 10.1002/ana.26158. Epub 2021 Jul 17. Ann Neurol. 2021. PMID: 34219266 Review.
Neonatal Fc Receptor-Targeted Therapies in Neurology.
Nelke C, Spatola M, Schroeter CB, Wiendl H, Lünemann JD. Nelke C, et al. Among authors: lunemann jd. Neurotherapeutics. 2022 Apr;19(3):729-740. doi: 10.1007/s13311-021-01175-7. Epub 2022 Jan 7. Neurotherapeutics. 2022. PMID: 34997443 Free PMC article. Review.
Complement activation contributes to GAD antibody-associated encephalitis.
Chuquisana O, Strippel C, Tröscher AM, Baumgartner T, Rácz A, Keller CW, Elger CE, Melzer N, Kovac S, Wiendl H, Bauer J, Lünemann JD. Chuquisana O, et al. Among authors: lunemann jd. Acta Neuropathol. 2022 Aug;144(2):381-383. doi: 10.1007/s00401-022-02448-x. Epub 2022 Jun 13. Acta Neuropathol. 2022. PMID: 35697881 Free PMC article. No abstract available.
143 results